Skip to main content
SpringerLink
Log in

Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: a randomized comparative trial

  • Original Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Increasing resistance against Helicobacter pylori has resulted in reduced eradication rates.

Objective

This study aims to determine whether eradication rates for H. pylori infection with sequential therapy is better than standard triple therapy.

Patients

Patients with endoscopy documented peptic ulcer and H. pylori infection confirmed by histology and rapid urease test.

Intervention

Patients were randomized into two groups; 134 received standard triple therapy (pantoprazole 40 mg, clarithromycin 500 mg and amoxicillin 1 g each administered twice daily) for 10 days and 138 received sequential regimen (pantoprazole 40 mg plus amoxicillin 1 g twice daily for 5 days followed by 40 mg pantoprazole, 500 mg clarithromycin, and 500 mg tinidazole each administered twice daily for 5 days). Eradication was confirmed by histology and rapid urease test. Compliance and adverse effects were determined by the recovery of empty medicine strips and questioning.

Results

The eradication rates with sequential therapy were significantly greater than with standard therapy on both intention-to-treat analysis (76.0 % vs. 61.9 %, p = 0.005; difference, 14.1 % [95 % CI, 6.5–19 %] and per protocol analysis (84.6 % vs. 67.4 %, p = 0.002; difference, 17.2 % [95 % CI, 8.5–23.5 %]). The incidence of side effects did not differ between the two therapy groups. One patient in standard therapy discontinued treatment due to side effects.

Limitation

Cultures were not performed. Loss to follow up was 5.2 % in standard therapy and 6.5 % in sequential therapy.

Conclusion

Sequential therapy was significantly more effective than standard therapy for eradicating H. pylori infection in peptic ulcer disease in Asian patients. Side effects were similar.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Graham DY, Adam E, Reddy GT, et al. Sero epidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991;36:1084–8.

    Article  PubMed  CAS  Google Scholar 

  2. Graham DY, Yamaoka Y. Ethical considerations of comparing sequential and traditional anti-Helicobacter therapy. Ann Intern Med. 2007;147:434–5.

    Article  PubMed  Google Scholar 

  3. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175–86.

    Article  PubMed  CAS  Google Scholar 

  4. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection a meta-analysis. Aliment Pharmacol Ther. 1999;13:857–64.

    Article  PubMed  CAS  Google Scholar 

  5. Perri F, Villani MR, Festa V, Quitadamo M, Andriulli A. Predictors of failure of Helicobacter pylori eradication with the standard ‘Maastricht triple therapy’. Aliment Pharmacol Ther. 2001;15:1023–9.

    Article  PubMed  CAS  Google Scholar 

  6. Bigard MA, Delchier JC, Riachi G, Thiabult P, Barthelemy P. One-week triple therapy using omeprazole, amoxicillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of Omeprazole and clarithromycin. Aliment Pharmacol Ther. 1998;12:383–8.

    Article  PubMed  CAS  Google Scholar 

  7. Calvet X, Ducons J, Guardiola J, et al. One-week triple versus quadruple therapy for Helicobacter pylori infection—a randomized trial. Aliment Pharmacol Ther. 2002;16:1261–7.

    Article  PubMed  CAS  Google Scholar 

  8. Deltenre M, Jonas C, van Gossum M, Buset M, Otero J, De Koster E. Omeprazole based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients. Eur J Gastroenterol Hepatol. 1995;7 suppl 1:S39–44.

    PubMed  Google Scholar 

  9. Vakil N. Helicobacter pylori eradication: sequential and traditional therapy. Gastroenterol Hepatol. 2009;3:59–64.

    Google Scholar 

  10. Ramakrishan BS. Helicobacter pylori infection in India: the case against eradication. Indian J Gastroenterol. 2006;25:25–7.

    Google Scholar 

  11. Thyagarajan SP, Ray P, Das BK, et al. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicenteric study. J Gastroenterol Hepatol. 2003;18:1373–8.

    Article  PubMed  CAS  Google Scholar 

  12. Datta S, Chattopadhyay S, Patra R, et al. Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy. Aliment Pharmacol Ther. 2005;22:51–7.

    Article  PubMed  CAS  Google Scholar 

  13. Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F. Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med. 2007;147:553–62.

    Article  PubMed  Google Scholar 

  14. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut. 2007;56:1353–7.

    Article  PubMed  CAS  Google Scholar 

  15. Zullo A, Hassan C, Morini S, et al. Sequential therapy for H. pylori an ‘aberrant’ therapy for general use. Dig Liver Dis. 2004;36:852–3.

    Article  PubMed  CAS  Google Scholar 

  16. Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication. A randomized trial. Ann Intern Med. 2007;146:556–63.

    Article  PubMed  Google Scholar 

  17. De Francesco V, Zullo A, Margiotta M, et al. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. Aliment Pharmacol Ther. 2004;19:407–14.

    Article  PubMed  Google Scholar 

  18. Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2000;14:715–8.

    Article  PubMed  CAS  Google Scholar 

  19. De Francesco V, Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori eradication: a randomized study. Dig Liver Dis. 2001;33:676–9.

    Article  PubMed  Google Scholar 

  20. Newcombe RG, Altman DG. Proportion and their differences. In: Altman DG, Machin D, Trevor NB, Newcombe RG (eds). Statistics with Confidences, 2nd ed. London: BMJ Books; 2000. pp 45–56.

  21. Kim YS, Kim SJ, Yoon JH, et al. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther. 2011;34:1098–105.

    Article  PubMed  CAS  Google Scholar 

  22. Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia. Clin Ther. 2008;30:528–34.

    Article  PubMed  CAS  Google Scholar 

  23. Park HG, Jung MK, Jung JT, et al. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients. Aliment Pharmacol Ther. 2012;35:56–65.

    Article  PubMed  CAS  Google Scholar 

  24. Laine L, Fennerty MB, Osato M, et al. Esomeprazole based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol. 2000;95:3393–8.

    Article  PubMed  CAS  Google Scholar 

  25. Vakil N, Lanza F, Schwartz H, Barth J. Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther. 2004;20:99–107.

    Article  PubMed  CAS  Google Scholar 

  26. Greenberg ER, Anderson GL, Morgan DR, et al. 14-Day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet. 2011;378:507–14.

    Article  PubMed  CAS  Google Scholar 

  27. Duck WM, Sobel J, Pruckler JM, et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons. United States Emerg Infect Dis. 2004;10:1088–94.

    Article  Google Scholar 

  28. Thyagarajan SP, Ray P, Das BK, et al. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicentric study. J Gastroenterol Hepatol. 2003;18:1373–8.

    Article  PubMed  CAS  Google Scholar 

  29. Bhatia V, Ahuja V, Das B, Bal C, Sharma MP. Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity. J Gastroenterol Hepatol. 2004;19:619–25.

    Article  PubMed  CAS  Google Scholar 

  30. De Francesco V, Margiotta M, Zullo A, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med. 2006;144:94–100.

    Article  PubMed  Google Scholar 

  31. Castro Fernández M, Sánchez Muñoz D, García Díaz E, Galán Jurado MV, Rodríguez AC. Diagnosis of Helicobacter pylori infection using urease rapid test in patients with bleeding duodenal ulcer: influence of endoscopic signs and simultaneous corporal and antral biopsies. Rev Esp Enferm Dig. 2004;96:599–602.

    PubMed  Google Scholar 

  32. Archimandritis A, Tzivras M, Sougioultzis S, et al. Rapid urease test is less sensitive than histology in diagnosing Helicobacter pylori infection in patients with non-variceal upper gastrointestinal bleeding. J Gastroenterol Hepatol. 2000;15:369–73.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, 190 011, India

    Gul Javid, Showkat Ali Zargar, Khurshid Bhat, Bashir Ahmad Khan, Ghulam Nabi Yatoo, Ghulam Mohamad Gulzar, Altaf Hussain Shah, Jaswinder Singh Sodhi, Mushtaq Ahmad Khan, Abid Shoukat & Riyaz U Saif

Authors
  1. Gul Javid
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Showkat Ali Zargar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Khurshid Bhat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bashir Ahmad Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ghulam Nabi Yatoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ghulam Mohamad Gulzar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Altaf Hussain Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jaswinder Singh Sodhi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mushtaq Ahmad Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Abid Shoukat
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Riyaz U Saif
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Showkat Ali Zargar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Javid, G., Zargar, S.A., Bhat, K. et al. Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: a randomized comparative trial. Indian J Gastroenterol 32, 190–194 (2013). https://doi.org/10.1007/s12664-013-0304-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-013-0304-7

Keywords

Search

Navigation